40 results
S-1
EX-10.15
ONCT
Oncternal Therapeutics Inc
15 Oct 03
IPO registration
12:00am
17.1 Recall Notification...................................................42
17.2 Recall Implementation in GTX Territory … ................................42
17.3 Recall Costs and Expenses in GTX Territory............................42
18. ADVERSE DRUG EXPERIENCES
8-K/A
EX-10.2
ONCT
Oncternal Therapeutics Inc
7 Mar 05
Entry into a Material Definitive Agreement
12:00am
18.1 RECALL NOTIFICATION. Each Party shall promptly notify the other
Party in writing of any facts relating to the advisability of the recall … ,
destruction or withholding from the market of the Product anywhere in the GTX
Territory (any of the foregoing, a "Recall").
18.2 RECALL
8-K/A
EX-10.1
ONCT
Oncternal Therapeutics Inc
7 Mar 05
Entry into a Material Definitive Agreement
12:00am
OF THE SECURITIES EXCHANGE ACT OF 1934, AS
AMENDED.
B-46
18. PRODUCT RECALLS
18.1 RECALL NOTIFICATION. Each … Party shall promptly notify the other Party
in writing of any facts relating to the advisability of the recall, destruction
or withholding from
10-Q
EX-10.24
0bnq0cj
7 May 04
Quarterly report
12:00am
8-K
EX-2.1
23iol628lnmw 2n1n8
3 Oct 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
xazekm 7y56r
21 Jul 20
Oncternal Therapeutics Announces $6.2 Million Registered Direct Offering
4:06pm
8-K
EX-10.1
msi47oqj
21 May 20
Oncternal Therapeutics Announces $5.0 Million Registered Direct Offering
4:31pm
S-1
92kv8ewrk9rn6m0e
15 Oct 03
IPO registration
12:00am
10-K
1swyw9
26 Mar 04
Annual report
12:00am